Literature DB >> 5013540

Effect of hydroxyurea on the radiation response of C3H mouse mammary tumors.

M S Piver, A E Howes, H D Suit, N Marshall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5013540     DOI： 10.1002/1097-0142(197202)29:2<407::aid-cncr2820290223>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  3 in total

1.  A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.

Authors:  J J Beitler; R V Smith; H Haynes; C E Silver; A Quish; T Kotz; M Serrano; A Brook; S Wadler
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

2.  Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas.

Authors:  F B Cvitkovic; C Haie-Meder; V Papadimitrakopoulou; J P Armand; C Cioloca; N Maugis; J P Constans
Journal:  J Neurooncol       Date:  1993-01       Impact factor: 4.130

3.  Ribonucleotide reductase inhibitors: a new look at an old target for radiosensitization.

Authors:  Tobias R Chapman; Timothy J Kinsella
Journal:  Front Oncol       Date:  2012-01-04       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.